• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性尿路上皮癌。

Metastatic urothelial carcinoma.

出版信息

Cancer Cell. 2021 May 10;39(5):583-585. doi: 10.1016/j.ccell.2021.04.012.

DOI:10.1016/j.ccell.2021.04.012
PMID:33974855
Abstract

Discovery-driven research and clinical research have worked together to change the outcomes of many cancer patients. We choose urothelial carcinoma as an example to showcase how recent diagnostic and therapeutic innovations have re-shaped cancer clinical practice.

摘要

以膀胱癌为例,展示了最近的诊断和治疗创新如何改变癌症临床实践。

相似文献

1
Metastatic urothelial carcinoma.转移性尿路上皮癌。
Cancer Cell. 2021 May 10;39(5):583-585. doi: 10.1016/j.ccell.2021.04.012.
2
[Prognostic factors in urothelial carcinoma].[尿路上皮癌的预后因素]
Urologe A. 2001 Nov;40(6):442-6. doi: 10.1007/s001200170002.
3
Skin metastasis of 'nested type' of urothelial carcinoma of the urinary bladder.膀胱尿路上皮癌“巢状型”的皮肤转移
J Cutan Pathol. 2006 Nov;33(11):754-5. doi: 10.1111/j.1600-0560.2006.00503.x.
4
Therapeutic strategies for upper tract urothelial carcinoma.上尿路尿路上皮癌的治疗策略。
Expert Rev Anticancer Ther. 2018 Aug;18(8):765-774. doi: 10.1080/14737140.2018.1481395. Epub 2018 Jun 8.
5
Cancer of the urogenital tract: bladder cancer. The accuracy of clinical vs. surgical staging.泌尿生殖道癌症:膀胱癌。临床分期与手术分期的准确性。
JAMA. 1968 Nov 18;206(8):1770-3 passim.
6
[Bladder carcinoma].[膀胱癌]
Ned Tijdschr Geneeskd. 1992 Jun 6;136(23):1097-102.
7
Re: Marko Babjuk, Willem Oosterlinck, Richard Sylvester, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303-14.回复:马尔科·巴布朱克、威廉·奥斯特林克、理查德·西尔维斯特等。欧洲泌尿外科学会非肌层浸润性膀胱癌指南。《欧洲泌尿外科杂志》2008年;54卷:303 - 314页。
Eur Urol. 2009 Jan;55(1):e15-6; author reply e17-8. doi: 10.1016/j.eururo.2008.07.071. Epub 2008 Aug 5.
8
[Treatment and follow-up of superficial bladder cancer].[浅表性膀胱癌的治疗与随访]
Duodecim. 2002;118(9):903-9.
9
α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.α4 通过调节 E-钙黏蛋白促进膀胱尿路上皮癌细胞侵袭和/或转移,是膀胱尿路上皮癌患者预后的预测因子。
Eur J Cancer. 2014 Mar;50(4):840-51. doi: 10.1016/j.ejca.2013.11.038. Epub 2014 Jan 2.
10
Urothelial Carcinoma With Villoglandular Differentiation: A Rare Entity.伴有绒毛腺性分化的尿路上皮癌:一种罕见实体。
Int J Surg Pathol. 2016 Jun;24(4):356-9. doi: 10.1177/1066896915621387. Epub 2015 Dec 31.

引用本文的文献

1
Advances in the immunological microenvironment and immunotherapy of bladder cancer.膀胱癌免疫微环境与免疫治疗的进展
Front Immunol. 2025 Aug 19;16:1609871. doi: 10.3389/fimmu.2025.1609871. eCollection 2025.
2
YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1/2 and JNK phosphorylation in the MAPK pathway.YWHAG通过调节TMOD3激活丝裂原活化蛋白激酶(MAPK)途径中的ERK1/2和JNK磷酸化来促进膀胱癌转移。
J Transl Med. 2024 Dec 31;22(1):1159. doi: 10.1186/s12967-024-06003-y.
3
Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells.
槲皮素和 mafosfamide 联合治疗膀胱癌细胞。
Molecules. 2024 Oct 31;29(21):5176. doi: 10.3390/molecules29215176.
4
BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.BHLHE41 通过调节 PYCR1 的稳定性来抑制膀胱癌的进展,从而使 PI3K/AKT 信号通路失活。
Eur J Med Res. 2024 May 29;29(1):302. doi: 10.1186/s40001-024-01889-2.
5
Application of nitroxoline in urologic oncology - a review of evidence.硝羟喹啉在泌尿肿瘤学中的应用——证据综述
Contemp Oncol (Pozn). 2024;28(1):1-8. doi: 10.5114/wo.2024.139584. Epub 2024 May 19.
6
Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer.谷胱甘肽动态变化是预测和治疗膀胱癌新辅助化疗反应的潜在特征。
Cell Rep Med. 2023 Oct 17;4(10):101224. doi: 10.1016/j.xcrm.2023.101224. Epub 2023 Oct 4.
7
The Efficacy and Safety of Tislelizumab as Adjuvant Treatment for Advanced or Metastatic Bladder Cancer in People Living With HIV: A Retrospective Multi-Center Study.特瑞普利单抗作为人免疫缺陷病毒(HIV)感染者的晚期或转移性膀胱癌辅助治疗的疗效和安全性:一项回顾性多中心研究。
Cancer Control. 2023 Jan-Dec;30:10732748231173475. doi: 10.1177/10732748231173475.
8
New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs.新型一氧化氮释放化合物有望成为抗膀胱癌药物。
Biomedicines. 2023 Jan 12;11(1):199. doi: 10.3390/biomedicines11010199.